香港股市 已收市

Zoetis Inc. (ZTS)

NYSE - NYSE 延遲價格。貨幣為 USD。
加入追蹤清單
167.07-0.16 (-0.10%)
收市:04:00PM EDT
168.00 +0.93 (+0.56%)
收市後: 06:28PM EDT

Zoetis Inc.

10 Sylvan Way
Parsippany, NJ 07054
United States
973 822 7000
https://www.zoetis.com

版塊Healthcare
行業Drug Manufacturers - Specialty & Generic
全職員工14,100

高階主管

名稱頭銜支付行使價出生年份
Ms. Kristin C. PeckCEO & Director3.54M5.2M1971
Mr. Wetteny N. JosephExecutive VP & CFO1.6M1972
Ms. Wafaa MamilliEVP, Chief Digital & Tech. Officer, Group President for China, Brazil and Preci. Animal Health1.36M1967
Ms. Heidi C. ChenEmployee Advisor1.24M1967
Dr. Robert J. Polzer Ph.D.Executive VP and President of Research & Development1.18M54.13k1969
Ms. Roxanne LaganoEVP, Chief HR Officer & Global Operations, Interim General Counsel and Corporate Secretary1965
Mr. Steven FrankVice President of Investor Relations
Mr. William PriceVP & Chief Communications Officer
Ms. Jeannette Ferran AstorgaExecutive VP of Corporate Affairs & Communications and Chief Sustainability Officer1975
Mr. Nick AshtonExecutive VP and President of Global Manufacturing & Supply1973
截止 2023年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.

公司管治

截至 2024年5月1日 止,Zoetis Inc. 的 ISS 管治質素評分為 3。 Pillar 分數正在審核中:5;董事會:2;股東權利:7;現金賠償:2。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。